Advertisement
Document › Details
European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy".
Region | EU (European Union) | |
Organisation | European Investment Bank (EIB) | |
Group | EU (govt) | |
Organisation 2 | ECBF (European Circular Bioeconomy Fund) (Group) | |
Product | European Circular Bioeconomy Fund SCSp I (ECBF SC Sp I) | |
Product 2 | industrial biotechnology | |
Index term | ECBF–SEVERAL: investment, 201911–202010 first closing €82m from cornerstone investor EIB + 3 private investors + target size of €250m | |
Person | McDowell, Andrew (EU (govt) 201812 VP at EIB) | |
Person 2 | Brandkamp, Michael (ECBF 202001– General Partner before Managing Director at High-Tech Gründerfonds) | |
> The European Commission and the European Investment Bank announce the selection of an Investment Advisor for the upcoming European Circular Bioeconomy Fund
> The fund aims to provide financing for innovative circular bioeconomy companies and projects in the EU and in countries associated with the Horizon 2020 programme
The European Commission and the European Investment Bank (EIB) have announced the completion of the public procurement process for the selection of an investment advisor to set up and manage the European Circular Bioeconomy Fund (ECBF). The selected investment advisor is ECBF Management GmbH and Hauck & Aufhäuser Fund Services S.A. will act as the Alternative Investment Fund Manager.
The new fund will provide access to finance – in the form of equity, debt or quasi-equity – to innovative circular bioeconomy companies and projects of various sizes. ECBF Management will raise funds from public and private investors with a target fund volume of EUR 250 million and aims for a first close in Q1 2020. A proposal for the EIB to invest up to EUR 100 million in the fund will be submitted to the EIB’s Board of Directors for approval. This investment will be backed by a guarantee from InnovFin – EU finance for Innovators, an initiative of the EIB Group and the European Commission to facilitate access to finance for innovation and research through a wide range of financing tools and advisory services.
Carlos Moedas, Commissioner for Research, Science and Innovation, said: “Sustainable bioeconomy has the potential to play a major role for the European Green Deal. It will help us reach our environmental, climate and biodiversity targets in line with the UN Sustainable Development Goals. The European Circular Bioeconomy Fund will fill the funding gaps, attracting private investments that bring bio-based innovations closer to the market.”
Andrew McDowell, EIB Vice-President responsible for agriculture and bioeconomy, said: “Using renewable biological resources to produce our goods and energy is essential to transition to a circular economy and reduce our reliance on fossil fuels. With the launch of the European Circular Bioeconomy Fund, we have reached an important milestone to ensure that groundbreaking projects in the sector get the financing they need.”
Michael Brandkamp, Head of ECBF, said: “It’s a great honour and privilege as well as an entrepreneurial obligation for us to be chosen by the EIB to execute this very important fund initiative. In the transforming industry we see great investment opportunities in Europe contributing to a sustainable circular economy. With more than 30 years of investment experience, the ECBF team has the right qualifications do the execution professionally. We are very grateful for the valuable support of the European Commission, the EIB, InnovFin, Hauck & Aufhäuser, and many other institutions and networking partners.”
The creation of such a fund was recommended by the 2017 Innovfin Advisory study Access-to-finance conditions for Investments in Bio-Based Industries and the Blue Economy which identified an important financing gap in the bioeconomy sector.
Background information
InnovFin – EU Finance for Innovators was launched, by the European Investment Bank Group (EIB and EIF) in cooperation with the European Commission under the EU Research and Innovation Framework Programme Horizon 2020. It aims to facilitate access to finance for innovation and research through a wide range of financing tools and advisory services, and secure Europe's global competitiveness.
In a transforming economy, the European Circular Bioeconomy Fund (ECBF) invests and partners with ambitious and visionary entrepreneurs to accelerate late stage companies. ECBF relies on expertise and powerful networks to catalyze sustainable innovations and fuel business growth. We aim to fill a funding gap in the European (bio-)economy, bringing Europe’s excellent expertise in circular technologies to market. ECBF will be established in Luxembourg, advised by an experienced venture capital team within ECBF Management GmbH and managed by Hauck & Aufhäuser Funds Services S.A. (AIFM). Being a market standard growth stage venture capital fund, ECBF has the additional ability to focus on project financing as well as typical venture capital investment structures. More information on the ECBF on www.ecbf.vc
Contact
Vanessa Paul
v.paul@eib.org
+352437984331
Press Office
press@eib.org
+352 4379 - 21000
Related tags
BioeconomyCircular economyInnovFin
Reference
2019-328-EN
Record changed: 2023-06-05 |
Advertisement
More documents for EU (govt)
- [1] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
- [2] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
- [3] Integra Therapeutics S.L.. (7/16/24). "Press Release: Integra Therapeutics to Receive up to €10.5 Million from European Commission for Its FiCAT Advanced Therapies Platform". Lausanne & San Francisco, CA....
- [4] Biovance Capital Partners. (7/9/24). "Press Release: Biovance Capital Partners Announces First Closing of Its New Biotech Fund at €51 million". Lisbon....
- [5] Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert....
- [6] Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
- [7] Biovance Capital Partners. (5/16/24). "Press Release: Biovance Capital Is the First Ever Investment in a Portuguese Life Sciences VC Fund by the EIF"....
- [8] Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC"....
- [9] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
- [10] SolasCure Ltd.. (11/3/23). "Press Release: SolasCure Awarded Prestigious European Innovation Council’s Accelerator Grant"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top